U.S. Court in Delaware Nixes AstraZeneca’s Challenge to Medicare Drug Price Negotiation Program
- March 08, 2024
A federal court in Delaware rejected March 1 AstraZeneca Pharmaceuticals LP’s bid to block implementation of the Medicare drug price negotiation program.
ARTICLE TAGS
You must be logged in to access this content.